The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 08, 2015

Filed:

May. 11, 2012
Applicants:

Scott D. Kuduk, Harleysville, PA (US);

Douglas C. Beshore, Lower Gwynedd, PA (US);

Zhi-qiang Yang, Schwenksville, PA (US);

Youheng Shu, Blue Bell, PA (US);

Daniel Pitts, Lansdale, PA (US);

Inventors:

Scott D. Kuduk, Harleysville, PA (US);

Douglas C. Beshore, Lower Gwynedd, PA (US);

Zhi-Qiang Yang, Schwenksville, PA (US);

Youheng Shu, Blue Bell, PA (US);

Daniel Pitts, Lansdale, PA (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 519/00 (2006.01); C07D 417/04 (2006.01); C07D 471/08 (2006.01); C07D 401/14 (2006.01); C07D 405/14 (2006.01); C07D 401/06 (2006.01); C07D 401/08 (2006.01); C07D 403/06 (2006.01); C07D 403/08 (2006.01); C07D 417/08 (2006.01); C07D 471/04 (2006.01); C07D 487/08 (2006.01); C07D 491/10 (2006.01); C07D 209/64 (2006.01);
U.S. Cl.
CPC ...
C07D 519/00 (2013.01); C07D 209/64 (2013.01); C07D 401/06 (2013.01); C07D 401/08 (2013.01); C07D 401/14 (2013.01); C07D 403/06 (2013.01); C07D 403/08 (2013.01); C07D 405/14 (2013.01); C07D 417/08 (2013.01); C07D 471/04 (2013.01); C07D 471/08 (2013.01); C07D 487/08 (2013.01); C07D 491/10 (2013.01);
Abstract

The present invention is directed to N-linked lactam compounds of general formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schizophrenia, pain or sleep disorders. The invention is also directed to pharmaceutical compositions comprising the compounds, and to the use of the compounds and compositions in the treatment of diseases mediated by the M1 receptor.


Find Patent Forward Citations

Loading…